<?xml version="1.0" encoding="UTF-8"?>
<SAMPLE_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <SAMPLE accession="ERS6182743" alias="E-MTAB-10317:siNT DMSO rep1" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182743</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497923</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT DMSO rep1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182744" alias="E-MTAB-10317:siNT DMSO rep2" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182744</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497924</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT DMSO rep2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182745" alias="E-MTAB-10317:siNT DMSO rep3" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182745</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497925</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT DMSO rep3</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182746" alias="E-MTAB-10317:siNT lapatinib rep1" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182746</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497926</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT lapatinib rep1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182747" alias="E-MTAB-10317:siNT lapatinib rep2" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182747</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497927</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT lapatinib rep2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182748" alias="E-MTAB-10317:siNT lapatinib rep3" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182748</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497928</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siNT lapatinib rep3</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182749" alias="E-MTAB-10317:siPPARGC1A DMSO rep1" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182749</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497929</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A DMSO rep1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182750" alias="E-MTAB-10317:siPPARGC1A DMSO rep2" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182750</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497930</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A DMSO rep2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182751" alias="E-MTAB-10317:siPPARGC1A DMSO rep3" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182751</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497931</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A DMSO rep3</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182752" alias="E-MTAB-10317:siPPARGC1A lapatinib rep1" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182752</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497932</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A lapatinib rep1</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182753" alias="E-MTAB-10317:siPPARGC1A lapatinib rep2" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182753</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497933</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A lapatinib rep2</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE accession="ERS6182754" alias="E-MTAB-10317:siPPARGC1A lapatinib rep3" broker_name="ArrayExpress" center_name="the university of manchester">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS6182754</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA8497934</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>siPPARGC1A lapatinib rep3</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
      <COMMON_NAME>human</COMMON_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>Protocols: OE19 cells were reverse transfected with siRNAs and then 24 hours post-transfection, cells were treated with DMSO or 500 nM lapatinib for 24 hours RNA was extracted using the RNeasy Plus Kit (Qiagen) RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>not applicable</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>OE19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>developmental stage</TAG>
        <VALUE>adult</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>disease</TAG>
        <VALUE>esophageal adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>organism part</TAG>
        <VALUE>esophagogastric junction</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_type</TAG>
        <VALUE>epithelial cell</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>genotype</TAG>
        <VALUE>wild type genotype</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2022-09-26</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
</SAMPLE_SET>
